Cleared Special

K222234 - GlucoSure ADVANCE Link Blood Glucose Mo...

K222234 is the FDA 510(k) clearance for GlucoSure ADVANCE Link Blood Glucose Mo... by Apex BioTechnology Corp.. It is a Class 2 Chemistry device (product code NBW) cleared through the Special 510(k) pathway after a 148-day FDA review.

K222234 · Apex BioTechnology Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
148d
Days
Class 2
Risk

K222234 is an FDA 510(k) clearance for the GlucoSure ADVANCE Link Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Apex BioTechnology Corp. (Hsinchu, CN). The FDA issued a Cleared decision on December 21, 2022 after a review of 148 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Apex BioTechnology Corp. devices

Submission Details

510(k) Number K222234 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2022
Decision Date December 21, 2022
Days to Decision 148 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d slower than avg
Panel avg: 88d · This submission: 148d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 235
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K222234.
Accu-Chek Guide Solo diabetes manager blood glucose monitoring system
K213131 · Roche Diabetes Care GmbH · Aug 2023
ReliOn Premier BLU Blood Glucose Monitoring System
K230625 · I-Sens, Inc. · Aug 2023
MIO Blood Glucose Monitoring System
K223722 · Mio Labs, Inc. · Jun 2023
CONTOUR® NEXT GEN Blood Glucose Monitoring System
K223293 · Ascensia Diabetes Care U.S., Inc. · Nov 2022
BGM039 Blood Glucose Monitoring System, BGM039 Link Blood Glucose Monitoring System
K220421 · Apex BioTechnology Corp. · Nov 2022
SuperCheck Pro Blood Glucose Monitoring System
K213061 · Ok Biotech Co., Ltd. · Oct 2022